Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.8

The market opened in the green on April 27, 2020, overall volumes in futures & options currently stand at 1.19 crore contracts with a turnover of Rs. 6,37,107.29 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 4.0

The market opened in the green on April 27, 2020, overall volumes in futures & options currently stand at 1.19 crore contracts with a turnover of Rs. 6,37,107.29 crore.

RBI to open special liquidity facility for mutual funds
RBI to open special liquidity facility for mutual funds

RBI to open special liquidity facility for mutual funds

Shashikant Singh Article rating: 2.5

On the back of higher redemption pressure faced by mutual fund houses in their debt funds as well as closing down of some debt MFs by a fund house, RBI has opened special liquidity facility for mutual funds.

NLC India commences coal production
NLC India commences coal production

NLC India commences coal production

Amir Shaikh Article rating: 3.0

NLC India informed the bourses on April 26 that the company has commenced coal production at Talabira-II & II opencast coal mine in the state of Odisha, having a normative capacity of 20 MTPA

JB Chemicals receive USFDA nod for Carbamazepine tablets
JB Chemicals receive USFDA nod for Carbamazepine tablets

JB Chemicals receive USFDA nod for Carbamazepine tablets

Apurva Joshi Article rating: 5.0

JB Chemicals & Pharmaceuticals Limited has received an approval from USFDA for its abbreviated new drug application (ANDA) for Carbamazepine extended-release tablets USP 100 mg, 200 mg and 400 mg.

IRB Infra board approves Rs 2,500 crore fundraising plan
IRB Infra board approves Rs 2,500 crore fundraising plan

IRB Infra board approves Rs 2,500 crore fundraising plan

Nidhi Jani Article rating: 5.0

This fundraising has been done majorly to meet the ongoing and planned capex requirements and cash flow mismatches of the company as well as for the general corporate purposes, in the wake of COVID-19, arising from the impact of the lockdown.

Granules India gets USFDA nod for Vigabatrin oral solution
Granules India gets USFDA nod for Vigabatrin oral solution

Granules India gets USFDA nod for Vigabatrin oral solution

Nidhi Jani Article rating: 5.0

As per IQVIA Health’s data, Vigabatrin for oral solution had US sales of approximately $255 million MAT for the most-recent twelve months, ending February 2020.

Index trend and stocks in action on April 27, 2020
Index trend and stocks in action on April 27, 2020

Index trend and stocks in action on April 27, 2020

Karan Dsij Article rating: 5.0

For the day, an immediate support for Nifty is placed around 9,070 and breach of this support zone would open for further correction towards 8,900. On the upside, 9,400 would continue to act as a stiff resistance for the index. Stocks in news: JK Cement, Natco Pharma, Tata Steel, Torrent Pharma, Granules.

Markets likely to begin on a positive note!
Markets likely to begin on a positive note!

Markets likely to begin on a positive note!

Karan Dsij Article rating: 5.0

The cues from global peers are setting up a firm pitch to bat on for the bulls. On Friday, with Franklin Templeton fiasco, which resulted to sell-off in the markets, it would be interesting to see whether the market participants recover from this wound or they will use today’s gap-up opening to liquidate their positions.

RSS
First21702171217221732175217721782179Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR